Doreen Agnese

Doreen Agnese, MD

  • Surgical Oncology
  • Genetics

Appointments: (614) 293-4040

About Me

I am a surgical oncologist, clinical geneticist and researcher who treats patients with breast cancer, melanoma and strong family histories of cancer. As a surgeon, I specialize in treating high-risk breast cancer patients and in assessing cutaneous, subcutaneous and nodal masses, and performing appropriate resections. As a geneticist, I advise patients on risk assessments based on family history, options for genetic testing and preventive screening, and treatments. My research focuses on all aspects of surgical oncology and cancer genetics, in particular breast tumors associated with the inheritable BRCA1 and BRCA2 genes, two of the most prominent genes associated with breast cancer risk. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016 and 2017.

In addition to my clinical work, I am committed to educating the next generation of oncologists. I teach and mentor young physicians, plan extension and continuing education programs, and train students in genetic counseling. I have published my work extensively in terms of both research and teaching. My writing has been published as book chapters, curriculum, reports and much more.

I also serve as a member of the Committee on Applicants for the American College of Surgeons (Ohio District #3).

Highlights

  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016, 2017
  • Named to the Castle Connolly list of America’s “Top Doctors” for 2017

Additional languages I speak

  • Spanish

Specialties and conditions I treat

  • Surgical Oncology
  • Genetics
  • Genes
  • Breast Cancer
  • Melanoma
  • Hereditary Breast and Ovarian Cancer Syndrome

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

Education and training

Medical Degree

M.D.
University of Medicine & Dentistry of New Jersey
5/31/1993

Residency

General Surgery
University of Medicine & Dentistry of New Jersey
7/1/1994 - 6/30/1999

More about my work

My background

Fellowships

Research
University of Medicine & Dentistry of New Jersey
7/1/1995 - 6/30/1996

Research
University of Medicine & Dentistry of New Jersey
7/1/1999 - 6/8/2001

Surgical Oncology
Ohio State University Wexner Medical Center
7/1/2001 - 6/30/2004

Surgical Oncology
Ohio State University Wexner Medical Center
7/1/2001 - 3/31/2002

Human Genetics
Ohio State University Wexner Medical Center
4/1/2003 - 3/31/2004

Board Certifications

American Board of Surgery
9/11/2000

American Board of Surgery
12/9/2009

My Departments

Internal Medicine

My Division

Human Genetics

Surgery

My Division

Surgical Oncology

Reviews

32 Patient Satisfaction Reviews

The patient satisfaction rating is an average of all responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page
  • Overall
    4.9 out of 5
  • Explains Things Clearly 4.8
  • Listens Carefully 4.8
  • Gives Understandable Instructions 5
  • Knows My Medical History 4.7
  • Shows Respect 4.9
  • Time Spent Together 5

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/28/2017, Dr. Agnese has reported no financial relationships with medical device, research and/or drug companies.